Addimmune
Rockville, US · 1 known investors
Addimmune develops gene therapy treatments for HIV, specifically AGT103-T, a first-in-class functional cure candidate that modifies patient immune cells to recognize and eliminate HIV-infected cells. The company is based in Rockville, Maryland and targets individuals living with HIV.
BiotechDeep TechDigital HealthMedical Devices
Founders & leadership
BW
Barry WellsMD
Investors · 1
In the news
- Addimmune Prepares to go Public, Initiate Phase Ib HIV Trial | BioBuzzbiobuzz.io · 2024
- 4 Biotech Executives Share Strategies Behind Successful Fund Raises | PM360pm360online.com · 2023
- News - Addimmuneaddimmune.com · 2023
- Investors - Addimmuneaddimmune.com · 2023
- Addimmune, a Clinical Stage Hiv-Focused Gene Therapy Company, to go Public Through Business Combination With 10x Capital Venture Acquisition Corp. IIIfinance.yahoo.com · 2023